SA’s BCG booster trials seek low-cost weapon against virus
Researchers expect preliminary results within six months in the year-long trial.
Wendell Roelf - The idea of testing the BCG vaccine in Africa against Covid-19 was bound to cause controversy, yet officials say efforts underway could, if successful, give the con
...
As jy n aktiewe intekenaar is en die artikel wys nie, meld asseblief af en weer aan. Gratis toegang tot artikels vanaf 12:00.
Kommentaar
Republikein
Geen kommentaar is op hierdie artikel gelaat nie